跳至主要内容
临床试验/NCT03328065
NCT03328065终止不适用

Viewpoints on the Social Representations and Rationale Concerning the Choices of Patients, Doctors and Caregivers With Regard to the Management of Patients With Non-resectable Metastatic Cancer of the Colon, Stomach, Bile Ducts, Rectum, Pancreas or Lung, or Gastrointestinal Neuroendocrine Tumours

Centre Hospitalier Universitaire Dijon1 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2017年12月19日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
36
试验地点
1
主要终点
Number of determinants which are privileged by the patients to choose a treatment

研究概览

简要总结

Reflexion on the therapeutic strategies to implement in patients at the end of life is advancing rapidly in France. However, beyond the choices presented to patients, sometimes even the decision to carry on, to limit or to stop treatments is also questioned. This decision is subjective; it is influenced by the patient's representation system (emotions, beliefs, values, practices, etc). In addition, even though he or she is the focus of the decision, the patient is not alone; other actors, accompanying the patient, play an important role in the final decision making. These actors, namely the doctors and close relatives, are also influenced in their decision making. This coexistence of representation systems may interfere with objective indicators that help in decision making (functional, clinical and biological) or with the knowledge acquired by doctors in their training and may complicate the decision-making process.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • I- PATIENTS
  • men or women
  • who have been informed about the study
  • and who have provided verbal consent to take part in the study
  • able to understand written and spoken French
  • with non-resectable metastatic cancer of: the colon, or the rectosigmoid junction or the stomach or bile ducts or rectum or gastrointestinal neuroendocrine tumor or lung (not small-cell cancer) or pancreas
  • with a caregiver designated as the principal caregiver (family, friend, neighbour)
  • who has consented to the principal caregiver taking part in a qualitative interview
  • able to take part in an interview lasting roughly one hour
  • II- CAREGIVERS
  • men or women
  • who have been informed about the study
  • who have provided verbal consent to take part in the study
  • able to understand written and spoken French
  • able to follow an interview lasting roughly one hour
  • III-DOCTORS
  • men or women
  • who have been informed about the study
  • who have provided verbal consent to take part in the study
  • specialised in specific organ or oncologist prescriber

排除标准

  • I- PATIENTS
  • under guardianship or ward of court
  • with a severe handicap (neurological disease: Parkinson, Alzheimer, other dementia, multiple sclerosis, severe mental retardation etc.)
  • II- CAREGIVERS
  • under guardianship or ward of court,
  • with a severe handicap (neurological disease: Parkinson, Alzheimer, other dementia, multiple sclerosis...),
  • with severe mental retardation impairing ability to understand.

结局指标

主要结局

Number of determinants which are privileged by the patients to choose a treatment

时间窗: through study completion, an average of 18 months

Type of determinants which are privileged by the patients to choose a treatment

时间窗: through study completion, an average of 18 months

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验